Psilocybin Laws in Maryland
Maryland has active psilocybin reform legislation and a growing research community. Maryland legalized recreational cannabis in 2023 and Johns Hopkins — home to some of the world's most influential psilocybin research — is located in Baltimore.
Current Legal Status
Active Legislation
Psilocybin remains Schedule I under Maryland law. Bills to establish a therapeutic psilocybin program have been introduced and are moving through the legislature, boosted by the proximity and prestige of Johns Hopkins research.
Key Legislation
HB 1111 (2024) proposed a regulated therapeutic psilocybin services framework — passed House Health Committee. SB 709 (2025) revised bill introduced with broader mental health framing, awaiting Senate vote.
Clinical Trials
Johns Hopkins Center for Psychedelic and Consciousness Research in Baltimore is one of the premier psilocybin research institutions in the world, with multiple ongoing trials for depression, addiction, PTSD, and end-of-life anxiety.
Advocacy Organizations
Johns Hopkins Center for Psychedelic and Consciousness Research, Maryland Psilocybin Advocacy, Healing Advocacy Fund.
Related Resources
Directory in Maryland
- Johns Hopkins Center for Psychedelic and Consciousness Research — Clinical Research
View all Maryland directory listings →
People in Maryland
- Roland Griffiths, Ph.D. (1944–2023) — Founding Director, Johns Hopkins Center for Psychedelic and Consciousness Research
- Matthew Johnson, Ph.D. — Professor of Psychiatry, Johns Hopkins; Associate Director, Center for Psychedelic and Consciousness Research
- Gül Dölen — Neuroscientist, Johns Hopkins University
- Rafael Lancelotta, M.S. — Research Scientist, Johns Hopkins Center for Psychedelic and Consciousness Research
- Nora D. Volkow, M.D. — Director, National Institute on Drug Abuse (NIDA)
See how Maryland compares to neighboring states and find therapy options for residents: